The impact of comorbidity on cancer survival: a review
Mette Søgaard,Reimar W. Thomsen,Kristine Skovgaard Bossen,Henrik Toft Sørensen,Mette Nørgaard +4 more
Reads0
Chats0
TLDR
In general, comorbidity does not appear to be associated with more aggressive types of cancer or other differences in tumor biology, and it is unclear from the literature whether the apparent undertreatment reflects appropriate consideration of greater toxicity risk, poorer clinical quality, patient preferences, or poor adherence among patients with comor bidity.Abstract:
Background A number of studies have shown poorer survival among cancer patients with comorbidity. Several mechanisms may underlie this finding. In this review we summarize the current literature on the association between patient comorbidity and cancer prognosis. Prognostic factors examined include tumor biology, diagnosis, treatment, clinical quality, and adherence. Methods All English-language articles published during 2002-2012 on the association between comorbidity and survival among patients with colon cancer, breast cancer, and lung cancer were identified from PubMed, MEDLINE and Embase. Titles and abstracts were reviewed to identify eligible studies and their main results were then extracted. Results Our search yielded more than 2,500 articles related to comorbidity and cancer, but few investigated the prognostic impact of comorbidity as a primary aim. Most studies found that cancer patients with comorbidity had poorer survival than those without comorbidity, with 5-year mortality hazard ratios ranging from 1.1 to 5.8. Few studies examined the influence of specific chronic conditions. In general, comorbidity does not appear to be associated with more aggressive types of cancer or other differences in tumor biology. Presence of specific severe comorbidities or psychiatric disorders were found to be associated with delayed cancer diagnosis in some studies, while chronic diseases requiring regular medical visits were associated with earlier cancer detection in others. Another finding was that patients with comorbidity do not receive standard cancer treatments such as surgery, chemotherapy, and radiation therapy as often as patients without comorbidity, and their chance of completing a course of cancer treatment is lower. Postoperative complications and mortality are higher in patients with comorbidity. It is unclear from the literature whether the apparent undertreatment reflects appropriate consideration of greater toxicity risk, poorer clinical quality, patient preferences, or poor adherence among patients with comorbidity. Conclusion Despite increasing recognition of the importance of comorbid illnesses among cancer patients, major challenges remain. Both treatment effectiveness and compliance appear compromised among cancer patients with comorbidity. Data on clinical quality is limited.read more
Citations
More filters
Journal ArticleDOI
Finding directionality and gene-disease predictions in disease associations
TL;DR: The results demonstrate that even though a large number of genes and metabolic pathways are shared between diseases of the same categories, inclusion levels between these genes and pathways are directional and independent of the disease classification.
Journal ArticleDOI
Effect of comorbidity on lung cancer diagnosis timing and mortality: A nationwide population-based cohort study in Taiwan
Shinechimeg Dima,Kun-Huang Chen,Kun-Huang Chen,Kung-Jeng Wang,Kung Min Wang,Nai Chia Teng,Nai Chia Teng +6 more
TL;DR: The presence of comorbid conditions was associated with early diagnosis of lung cancer and survival in lung cancer patients in Taiwan by using a nationwide population-based study design.
Journal ArticleDOI
Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.
Arnaud Seigneurin,Patricia Delafosse,Brigitte Trétarre,Anne-Sophie Woronoff,Michel Velten,Pascale Grosclaude,A.V. Guizard,Bénédicte Lapôtre-Ledoux,Simona Bara,Florence Molinié,Marc Colonna +10 more
TL;DR: After adjustment for age, sex, stage and diagnostic mode, the presence of comorbidity based on CCI grades 1–2 and 3 was associated with lower survival rates for small cell cancers whereas no differences were observed for adenocarcinomas and squamous cell cancers.
Journal ArticleDOI
How to model temporal changes in comorbidity for cancer patients using prospective cohort data
Lars Lindhagen,Mieke Van Hemelrijck,Mieke Van Hemelrijck,David Robinson,Paer Stattin,Hans Garmo +5 more
TL;DR: A method to model temporal changes in CCI in cancer patients using data from PCBaSe Sweden, a nation-wide population-based prospective cohort of men diagnosed with prostate cancer efficiently captures changes in comorbidity over time with a small number of regression analyses to perform.
Journal ArticleDOI
Survival Status and Predictors of Mortality Among Colorectal Cancer Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Retrospective Followup Study
TL;DR: It is crucial to implement early detection and screening, giving priority to rural dweller, comorbid patients and advanced stage diagnosed patients.
References
More filters
Journal ArticleDOI
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆
TL;DR: The method of classifying comorbidity provides a simple, readily applicable and valid method of estimating risk of death fromComorbid disease for use in longitudinal studies and further work in larger populations is still required to refine the approach.
Journal ArticleDOI
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
TL;DR: The findings challenge the single-disease framework by which most health care, medical research, and medical education is configured, and a complementary strategy is needed, supporting generalist clinicians to provide personalised, comprehensive continuity of care, especially in socioeconomically deprived areas.
Journal ArticleDOI
A dictionary of epidemiology
TL;DR: The new edition of this classic text remains the definitive dictionary in epidemiology, and the dictionary goes beyond simple definitions, as it place each term firmly and clearly in its fuller epidemiologic context.
Journal ArticleDOI
Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
TL;DR: There is substantial under representation of patients 65 years of age or older in studies of treatment for cancer, and the reasons should be clarified, and policies adopted to correct this underrepresentation.
Journal ArticleDOI
Cumulative illness rating scale.
TL;DR: A Cumulative Illness Rating Scale, designed to meet the need for a brief, comprehensive and reliable instrument for assessing physical impairment, has been developed and tested and is well suited to a variety of research uses.